With the development of biomedical research, some molecular biomarkers have been identified to be associated with NPC prognosis, such as plasma EBV DNA, serum amyloid protein A (SAA), sailic acid (SA), EGFR and CENP-H. The gene discussed is EGFR; the disease is nasopharyngeal carcinoma.